Gainers
- Renovaro (NASDAQ:RENB) stock rose 51.3% to $0.76 during Thursday's after-market session. The company's market cap stands at $116.9 million.
- AIM ImmunoTech (AMEX:AIM) shares increased by 11.57% to $0.27. The market value of their outstanding shares is at $15.4 million.
- Phathom Pharmaceuticals (NASDAQ:PHAT) shares rose 7.63% to $19.5. The company's market cap stands at $1.3 billion.
- Outlook Therapeutics (NASDAQ:OTLK) stock moved upwards by 7.04% to $5.62. The company's market cap stands at $132.9 million.
- Roivant Sciences (NASDAQ:ROIV) shares increased by 4.99% to $11.77. The company's market cap stands at $8.7 billion.
- Century Therapeutics (NASDAQ:IPSC) shares increased by 4.63% to $1.58. The market value of their outstanding shares is at $133.8 million.
Losers
- Avinger (NASDAQ:AVGR) stock fell 8.5% to $1.18 during Thursday's after-market session. The company's market cap stands at $2.5 million.
- Carmell (NASDAQ:CTCX) shares decreased by 7.57% to $0.34. The company's market cap stands at $7.1 million.
- Ainos (NASDAQ:AIMD) stock fell 7.41% to $0.5. The market value of their outstanding shares is at $4.0 million.
- Theriva Biologics (AMEX:TOVX) stock declined by 5.03% to $1.7. The market value of their outstanding shares is at $2.3 million.
- 2seventy bio (NASDAQ:TSVT) stock fell 4.85% to $4.52. The company's market cap stands at $232.7 million.
- Bone Biologics (NASDAQ:BBLG) shares fell 4.52% to $1.69. The company's market cap stands at $3.0 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
